Inside burn patients’ skin cells are regenerative forces at the ready. Give Them the Signal to Move.

Inside burn patients’ skin cells are regenerative forces at the ready.
Give Them the Signal to Move.

Elevating the standard of care through

Immediate Cellular Delivery

Point-of-care regenerative therapy in a single procedure

The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds in patients 18 years of age and older.1

Careers

About RECELL System

Careers

About RECELL System

The RECELL System is a device that enables healthcare professionals to produce a suspension of Spray-On Skin™ Cells using a small sample of the patient’s own skin.

LEARN MORE
Chest

Healthcare Professional Resources

Chest

Healthcare Professional Resources

See the extensive data available for RECELL® and access resources for you and your patients.

LEARN MORE
Recell Top Angled Open

Reimbursement

Recell Top Angled Open

Reimbursement

Assistance with physician and hospital reimbursement is available through our support team (833) GO-AVITA

LEARN MORE

Do more for your patient in the moment:

Reduced Donor Skin Requirements

with up to 80:1 expansion ratio1

Prepare and Apply In a Single Procedure

for immediate use in the same operative setting1

Reduced Costs

including total treatment costs and length of stay2

References

  1. Instructions for Use. RECELL® Autologous Cell Harvesting Device.

  2. Kowal S, Kruger E, Bilir P, et al. Cost-effectiveness of RECELL, an autologous cell harvesting device versus standard of care for treatment of severe burns in the United States. Presented at the International Society for Health Economics and Outcomes 2018 Annual Meeting, May 2018.


Important Safety Information

Indications for Use: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds in patients 18 years of age and older. The RECELL® device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous Regenerative Epidermal Suspension (RES™) for direct application to acute partial-thickness thermal burn wounds or application in combination with meshed autografting for acute full-thickness thermal burn wounds.

Contraindications: RECELL® is contraindicated for: the treatment of wounds clinically diagnosed as infected or with necrotic tissue, the treatment of patients with a known hypersensitivity to trypsin or compound sodium lactate (Hartmann’s) solution, patients having a known hypersensitivity to anesthetics, adrenaline/epinephrine, povidone-iodine, or chlorhexidine solutions.

Warnings: Autologous use only. Wound beds treated with a cytotoxic agent (e.g., silver sulfadiazine) should be rinsed prior to application of the cell suspension. RECELL® is provided sterile and is intended for single-use. Do not use if packaging is damaged or expired. Choose a donor site with no evidence of cellulitis or infection and process skin immediately. A skin sample should require between 15 and 30 minutes contact with Enzyme. Contact in excess of 60 minutes is not recommended. RECELL® Enzyme is animal derived and freedom from infectious agents cannot be guaranteed.

Precautions: RECELL® is not intended for use without meshed autograft for treatment of full-thickness burn wounds. The safety and effectiveness of RECELL® without meshed autograft have not been established for treatment of partial-thickness burn wounds: on the hands and articulating joints, >320 cm2, in patients with wounds totaling >20% total body surface area (TBSA). The safety and effectiveness of RECELL® with autografting have not been established for treatment of full-thickness burn wounds: on the hands and articulated joints, in patients with wounds totaling >50% TBSA.

Special Patient Populations: The safety and effectiveness of RECELL® have not been established for treatment of acute thermal partial-thickness or full-thickness burn wounds in pediatric patients younger than 18 years of age. For complete Important Safety Information, refer to Instructions For Use.

Important Safety Information

Indications for Use: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds in patients 18 years of age and older. The RECELL® device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous Regenerative Epidermal Suspension (RES™) for direct application to acute partial-thickness thermal burn wounds or application in combination with meshed autografting for acute full-thickness thermal burn wounds.

Contraindications: RECELL® is contraindicated for: the treatment of wounds clinically diagnosed as infected or with necrotic tissue, the treatment of...

JOIN OUR COMMUNITY

BE THE FIRST TO RECEIVE NEWS, UPDATES, AND EVENT INFORMATION FROM AVITA MEDICAL.

CONTACT US

US Customer Service Number:


1-833-GO-AVITA

Or 1-833-462-8482

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.